The renin-angiotensin system and blood pressure differences between blacks and whites

American Journal of Hypertension

Volumn 12, Issue 6, 1999, Pages 555-562

  He, Jiang ^a   Klag, Michael J ^b,c,d   Appel, Lawrence J ^b,c,d   Charleston, Jeanne ^d   Whelton, Paul K ^a  

^a TULANE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Angiotensin converting enzyme; Blacks; Blood pressure; Hypertension; Renin activity

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ADULT; ARTICLE; BLOOD PRESSURE; CAUCASIAN; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RACE DIFFERENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE;

EID: 0033038583     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00030-8     Document Type: Article

References (47)

1. Cornoni-Huntley J., LaCroix A.Z., Havlik R.J. Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I epidemiologic follow-up study. Arch Intern Med. 149:1989;780-788.
2. Drizd T, Dannenberg AL, Engel A: Blood pressure levels in persons 18-74 years of age in 1976-80, and trends in blood pressure from 1960 to 1980 in the United States. Vital and Health Statistics. 1986; Series 11, No. 234. DHHS Pub. (PHS) 86-1684.
3. Burt V.L., Whelton P.K., Roccella E.J., et al. Prevalence of hypertension in the US adult population. Results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 25:1995;305-313.
4. Mantunga A.K., Jones J.J., Pratt H. Longitudinal assessment of blood pressures in black and white children. Hypertension. 22:1993;84-89.
5. Klag M.J., Whelton P.K., Randall B.L., et al. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA. 277:1997;1293-1298.
6. Saunders E. Hypertension in minorities blacks . Am J Hypertens. 8:1995;115S-119S.
7. Blaustein M.P., Grim C.E. The pathogenesis of hypertension black-white differences . Cardiovasc Clin. 21:1991;97-114.
8. Falkner B. Differences in blacks and whites with essential hypertension biochemistry and endocrine. State of the art lecture . Hypertension. 15:1990;681-686.
9. Helmer O.M. Renin activity in blood from patients with hypertension. Can Med Assoc J. 38:1964;221-225.
10. Helmer O.M., Judson W.E. Metabolic studies on hypertensive patients with suppressed plasma renin activity not due to hyperaldosteronism. Circulation. 38:1968;965-970.
11. Luft F.C., Rankin L.I., Block R., et al. Cardiovascular and humoral response to extremes of sodium intake in normal white and black men. Circulation. 60:1979;697-706.
12. Hohn A.R., Piopel D.A., Djeil J.E., et al. Child familial and racial differences in physiologic and biochemical factors related to hypertension. Hypertension. 5:1983;56-70.
13. Grim C.E., Luft F.C., Miller J.Z., et al. Racial differences in blood pressure in Evans County, Georgia relationship to sodium and potassium intake and plasma renin activity . J Chronic Dis. 33:1980;87.
14. James G.D., Sealey J.E., Muller F., et al. Renin relationship to sex, race and age in a normotensive population. J Hypertens. 4:(suppl):1986;S387-S389.
15. Urinary and serum electrolytes in untreated black and white hypertensives. J Chron Dis. 40:1987;839-847.
16. Pratt J.H., Jones J.J., Miller J.Z., et al. Racial differences in aldosterone excretion and plasma aldosterone concentrations in children. N Eng J Med. 321:1989;1152-1157.
17. Harshfield G.A., Alpert B.S., Pulliam D.A. Renin-angiotensin-aldosterone system in healthy subjects aged ten to eighteen years. J Pediatrics. 122:1993;563-567.
18. Fisher N.D.L., Gleason R.E., Moore T.J., et al. Regulation of aldosterone secretion in hypertensive blacks. Hypertension. 23:1994;179-184.
19. Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide. Br J Clin Pharmacol. 14:1982;97s-101s.
20. Materson B.J., Reda D.J., Cushman W.C., et al. Single drug therapy for hypertension in men a comparison of six antihypertensive agents with placebo . N Engl J Med. 3281:1993;914-921.
21. Weir M.R., Gray J.M., Paster R., et al. Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. Hypertension. 25:1995;124-130.
22. Niarchos A.P., Resnick L.M., Weinstein D.L., et al. Angiotensin I converting enzyme activity in hypertension. Relationship to blood pressure, renin-sodium profiles, and antihypertensive therapy. Am J Med. 79:1985;435-444.
23. Satterfield S., Cuttler J.A., Langford H.G., et al. Trials of hypertension prevention, phase 1 design. Ann Epidemiol. 1:1991;455-471.
24. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention Phase 1. JAMA. 267:1992;1213-1220.
25. Wright B.M., Dore L.F. A random-zero sphygmomanometer. Lancet. i:1970;337-338.
26. Keys A., Fidanza F., Karvonen M.J., et al. Indices of relative weight and obesity. J Chron Dis. 25:1972;329-343.
27. Haber E., Koener T., Page L.B., et al. Applications of radioimmunoassay for angiotensin I to the physiological measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 29:1969;1349-1355.
28. Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med. 59:1975;365-372.
29. SAS Institute Inc: SAS/STAT User's guide, 1991, release 6.03. SAS Institute Inc., Cary, NC.
30. Walker W.G., Whelton P.K., Saito H., et al. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension. 1:1979;287-291.
31. Chau N.P., Chanudet X., Larroque P. Inverse relationship between upright plasma renin activity and twenty-four hour blood pressure variability in borderline hypertension. J Hypertension. 8:1990;913-918.
32. Meade T.W., Imeson J.D., Gordon D., et al. The epidemiology of plasma renin. 64:1983;273-280.
33. Sealey J.E., Laragh J.H. The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis. Laragh J.H., Brenner B.M. Hypertension Pathophysiology, Diagnosis, and Management . 1990;1287-1317 Raven, New York.
34. Hackenthal E., Nobiling R. Renin secretion and its regulation. Swales J.D. Textbook of Hypertension. 1994;735-740 Blackwell Scientific, Oxford.
35. Bianchi G., Cusi D., Gatti M., et al. A renal abnormality as a possible cause of "essential" hypertension. Lancet. i:1979;173-177.
36. Bianchi G., Picotti G.B., Bracchi G., et al. Relationship between kidney function and familial hypertension in young normotensive subjects. Yamori Y. Prophylactic Approach to Hypertensive Disease. 1979;157-163 Raven, New York.
37. van Hooft I.M.S., Grobbee D.E., Derkx F.H.M., et al. Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents. N Engl J Med. 324:1991;1305-1311.
38. Rey C., Santos F., Malaga S., et al. Renin, kallikrein and prostaglandin renal systems in normotensive boys with and without a family history of essential hypertension. J Cardiovasc Risk. 2:1995;143-148.
39. Langford H.G., Cushman W.C., Hsu H. Chronic effect of KCl on black-white differences in plasma renin activity, aldosterone, and urinary electrolytes. Am J Hypertens. 4:(5 Pt 1):1991;399-403.
40. Torretti J. Sympathetic control of renin release. Ann Rev Pharmacol & Toxicol. 22:1982;167-192.
41. Bloem L.J., Manatunga J., Pratt. Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension. 27:1996;62-66.
42. Reams G.P. Angiotensin-converting enzyme in renal and cerebral tissue and implications for successful blood pressure management. Am J Cardiol. 69:1992;59C-64C.
43. Laragh J.H., Baer L., Brunner H.R., et al. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med. 52:1972;633-652.
44. Sagnella G.A., Markandu N.D., Buckley M.G., et al. Plasma atrial natriuretic peptide, aldosterone, and plasma renin activity response to gradual changes in dietary sodium intake. Am J Hypertens. 3:1990;863-865.
45. Ljungman S., Aurell M., Hartford M., et al. Blood pressure in relation to the renin-angiotensin-aldosterone system. Acta Medica Scand. 211:1982;351-360.
46. Thulin T., Karlberg B.E., Schersten B. Plasma renin activity, aldosterone and sodium excretion in women with high and low casual blood pressure levels. Acta Med Scand. 203:1978;405-410.
47. Thomas G.W., Ledingham J.G.G., Beilin L.J., et al. Reduced plasma renin activity in essential hypertension effects of blood pressure, age and sodium . Clin Sci Mol Med. 3:(suppl):1976;185s-188s.